Select Page
Anivive Awarded FDA Grant for Canine Cancer Research

Anivive Awarded FDA Grant for Canine Cancer Research

The U.S. Food and Drug Administration (FDA) has awarded Anivive, a pet health tech company, a $500,000 USD grant to continue research on  LAVERDIA™ -CA1 (verdinexor) and its effect on treating canine cancer. As one of four companies selected for the MUMS grant,...
UDI Guidance Finalized by FDA

UDI Guidance Finalized by FDA

The U.S. Food and Drug Administration (FDA) has finalized UDI guidance content requirements and form for unique device identifiers (UDIs), after five years from its first drafted release. The guidance covers two types of UDIs, including automatic identification and...